|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM37020557X |
| 003 |
DE-627 |
| 005 |
20240814232235.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
240328s2024 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.3928/23258160-20240208-02
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1501.xml
|
| 035 |
|
|
|a (DE-627)NLM37020557X
|
| 035 |
|
|
|a (NLM)38531003
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Finn, Matthew J
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Widefield, Swept-Source Optical Coherence Tomography Angiography Metrics as Predictors of Anti-VEGF Treatment in Retinal Vein Occlusions
|
| 264 |
|
1 |
|c 2024
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 16.07.2024
|
| 500 |
|
|
|a Date Revised 14.08.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a BACKGROUND AND OBJECTIVE: Our objective was to assess baseline widefield swept-source optical coherence tomography angiography (WF SSOCTA) microvascular metrics as predictors for the number of anti-vascular endothelial growth factor (VEGF) injections and visual acuity (VA) at 12-months follow-up in patients with retinal vein occlusion (RVO)
|
| 520 |
|
|
|a PATIENTS AND METHODS: This was a prospective study including 49 RVO eyes from 49 patients who had not received an anti-VEGF injection for at least 3 months prior to imaging. Microvascular metrics from 6×6-mm and 12×12-mm angiograms were assessed using linear regression models, adjusting for age
|
| 520 |
|
|
|a RESULTS: Reductions in the vessel density (VD) and vessel skeletonized density (VSD) vascular metrics were associated both with a higher number of anti-VEGF injections at all follow-up time points and reduced VA 12 months after imaging in all RVO eyes
|
| 520 |
|
|
|a CONCLUSIONS: WF SS-OCTA VD and VSD micro-vascular metrics at baseline can prognosticate VA and number of anti-VEGF injections required at 3, 6, and 12 months in RVO eyes. [Ophthalmic Surg Lasers Imaging Retina 2024;55:374-382.]
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
7 |
|a Angiogenesis Inhibitors
|2 NLM
|
| 650 |
|
7 |
|a Vascular Endothelial Growth Factor A
|2 NLM
|
| 650 |
|
7 |
|a Ranibizumab
|2 NLM
|
| 650 |
|
7 |
|a ZL1R02VT79
|2 NLM
|
| 700 |
1 |
|
|a Baldwin, Grace
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Lains, Ines
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Garg, Itika
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wescott, Hannah
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Vingopoulos, Filippos
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zeng, Rebecca
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Choi, Hanna
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Tracy, Jack
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Razavi, Peyman
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Sayeh, Diane
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Patel, Nimesh A
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wu, David M
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Vavvas, Demetrios G
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Miller, John B
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Ophthalmic surgery, lasers & imaging retina
|d 2013
|g 55(2024), 7 vom: 01. Juli, Seite 374-382
|w (DE-627)NLM224956647
|x 2325-8179
|7 nnns
|
| 773 |
1 |
8 |
|g volume:55
|g year:2024
|g number:7
|g day:01
|g month:07
|g pages:374-382
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.3928/23258160-20240208-02
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_31
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_63
|
| 912 |
|
|
|a GBV_ILN_65
|
| 912 |
|
|
|a GBV_ILN_69
|
| 912 |
|
|
|a GBV_ILN_70
|
| 912 |
|
|
|a GBV_ILN_90
|
| 912 |
|
|
|a GBV_ILN_91
|
| 912 |
|
|
|a GBV_ILN_130
|
| 912 |
|
|
|a GBV_ILN_135
|
| 912 |
|
|
|a GBV_ILN_136
|
| 912 |
|
|
|a GBV_ILN_151
|
| 912 |
|
|
|a GBV_ILN_181
|
| 912 |
|
|
|a GBV_ILN_203
|
| 912 |
|
|
|a GBV_ILN_217
|
| 912 |
|
|
|a GBV_ILN_235
|
| 912 |
|
|
|a GBV_ILN_289
|
| 912 |
|
|
|a GBV_ILN_294
|
| 912 |
|
|
|a GBV_ILN_297
|
| 912 |
|
|
|a GBV_ILN_350
|
| 912 |
|
|
|a GBV_ILN_352
|
| 912 |
|
|
|a GBV_ILN_674
|
| 912 |
|
|
|a GBV_ILN_676
|
| 912 |
|
|
|a GBV_ILN_688
|
| 912 |
|
|
|a GBV_ILN_698
|
| 912 |
|
|
|a GBV_ILN_721
|
| 912 |
|
|
|a GBV_ILN_737
|
| 912 |
|
|
|a GBV_ILN_791
|
| 912 |
|
|
|a GBV_ILN_812
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 55
|j 2024
|e 7
|b 01
|c 07
|h 374-382
|